This inventor holds 1 USPTO granted patent. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Naoko Tomizawa: Innovator in Colorectal Cancer Treatment
Introduction
Naoko Tomizawa is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of medicinal compositions, particularly in the treatment of colorectal cancer. His innovative approach focuses on utilizing specific inhibitors to enhance treatment efficacy.
Latest Patents
Naoko Tomizawa holds 1 patent for his work titled "Medicinal compositions for treating colorectal cancer." This patent describes compositions designed to be administered to the large intestine, leveraging preparations that disintegrate in that area. The compositions are characterized by containing a cyclooxygenase inhibitor and an HMG-CoA reductase inhibitor. These formulations are particularly effective in inhibiting postoperative liver metastasis and recurrence of colorectal cancer.
Career Highlights
Tomizawa is associated with Hisamitsu Pharmaceutical Company, Inc., where he continues to develop innovative solutions for cancer treatment. His work has garnered attention for its potential to improve patient outcomes in colorectal cancer therapy.
Collaborations
Naoko Tomizawa has collaborated with notable colleagues, including Norifumi Tanida and Takeshi Goto. Their combined expertise contributes to the advancement of research and development in the pharmaceutical field.
Conclusion
Naoko Tomizawa's contributions to medicinal compositions for colorectal cancer highlight his dedication to improving treatment options. His innovative work continues to pave the way for advancements in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile